A class of compounds that bind to fatty acid binding protein (FABP4) and modulate adipocyte metabolism to drive enhanced glucose utilization, as well as pharmaceutical compositions comprising the class of compounds, in combination with a pharmaceutically acceptable diluent or carrier, and optionally, further in combination with a therapeutically active agent, and the use of these compounds in medicine and for the preparation of a medicament in the treatment of disorders acting on the FABP4.
一类化合物,能够结合到
脂肪酸结合蛋白(FABP4)并调节脂肪细胞代谢以促进增强
葡萄糖利用,以及包含该类化合物的药物组合物,与
药用辅料或载体相结合,并可选地进一步与治疗活性剂相结合,以及这些化合物在医学上的应用和用于制备治疗作用于FABP4的疾病的药物。